SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review

K Narang, EAL Enninga, MDSK Gunaratne… - Mayo Clinic …, 2020 - Elsevier
… disease 2019 (COVID-19), has been associated with worse outcomes in several patient …
or exacerbate the clinical presentation of COVID-19. Specifically, SARS-CoV-2 enters the cell …

[HTML][HTML] Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19

R Yadav, JK Chaudhary, N Jain, PK Chaudhary… - Cells, 2021 - mdpi.com
coronavirus-2 (SARS-CoV-2), and found to be the causative agent of coronavirus disease-19
(COVID-19… , 79% with SARS-CoV and 50% with MERS-CoV, respectively. Despite key …

SARS-CoV-2 (COVID-19): what do we know about children? A systematic review

NS Mehta, OT Mytton, EWS Mullins… - Clinical Infectious …, 2020 - academic.oup.com
… Few pediatric cases of coronavirus disease 2019 (COVID-19) have been reported and
we … coronavirus 2 (SARS-CoV-2), in order to inform clinical and public health measures. …

[HTML][HTML] The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic

SP Otto, T Day, J Arino, C Colijn, J Dushoff, M Li… - Current Biology, 2021 - cell.com
… One year into the global COVID-19 pandemic, the focus of attention has shifted to the
emergence and spread of SARS-CoV-2 variants of concern (VOCs). After nearly a year of the …

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

Y Toyoshima, K Nemoto, S Matsumoto… - Journal of human …, 2020 - nature.com
… showing different fatality rates of COVID-19. In correlation analyses, we … Our findings suggest
that SARS-CoV-2 mutations as well as … to SARS-CoV-2 infection or severity of COVID-19. …

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

DR Owen, CMN Allerton, AS Anderson… - Science, 2021 - science.org
… by COVID-19. Here, we report the discovery and characterization of PF-07321332, an
orally bioavailable SARS-CoV-2 main protease inhibitor with in vitro pan-human coronavirus

Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung

G Bulfamante, T Bocci, M Falleni, L Campiglio… - Journal of …, 2021 - Springer
… features in two patients who died of COVID-19 and in two COVID-19 negative patients as
controls. … Other features studied were the immunohistochemical expression of the SARS-CoV-2 …

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

IP Trougakos, K Stamatelopoulos, E Terpos… - Journal of Biomedical …, 2021 - Springer
… Likewise, extensive lung infection by SARS-CoV-2 in COVID-19, triggers capillary leakage
… examination of patients with COVID-19 revealed the existence of SARS-CoV-2 in multiple (…

The presence of SARSCoV‐2 RNA in the feces of COVID19 patients

Y Chen, L Chen, Q Deng, G Zhang, K Wu… - Journal of medical …, 2020 - Wiley Online Library
… respiratory syndrome coronavirus 2 (SARS-CoV-2)… SARS-CoV-2 has not been fully
understood. In this study, we aimed to investigate SARS-CoV-2 shedding in the excreta of COVID-19

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection

M Patone, L Handunnetthi, D Saatci, J Pan… - Nature medicine, 2021 - nature.com
… and 145 excess cases per 10 million people after a positive SARS-CoV-2 test. In summary,
COVID-19 vaccines, the risk of these complications is greater following a positive SARS-CoV-…